IVIM Health vs Telos Rx: Pricing, Ratings, Protocols Compared
Quick verdict: IVIM Health vs Telos Rx
If you prioritize verified third-party ratings and a clinician-guided protocol, IVIM Health stands out; if your top priority is lower advertised starting price, Telos Rx lists semaglutide as low as $99 per month. This comparison highlights pricing, third-party ratings, membership and consult offers, proprietary protocol claims, and compounded medication notices to help you choose.
See IVIM Health details and use code GIFT75
Side by side: the most distinctive differences
We compare IVIM Health and Telos Rx directly across five supported differences drawn from the source material: advertised starting price, third-party ratings and trust signals, free consult and membership offers, proprietary protocol claims, and regulatory status of compounded medications.
1. Advertised starting price and pricing details
IVIM Health lists semaglutide and tirzepatide pricing with a specific program fee and published month rates: semaglutide at $75/mo in captured landing details and tirzepatide at $133/mo plus a $74.99/mo program fee. IVIM’s FAQ also states $99 first month and $174/month ongoing for a clinician-guided program. Telos Rx advertises semaglutide as low as $99 per month and tirzepatide as low as $139 per month, noting prices apply if a licensed provider approves you and that your price depends on your plan. Telos also emphasizes pay $0 if not approved language in captured copy.
Check Telos Rx starting prices
2. Third-party ratings and trust signals
IVIM Health is presented as having an unusually strong dual verification: a 4.9-star rating on both Google and Trustpilot, which the source calls a rare dual third-party verification. Telos Rx captured landing content did not include verified third-party rating claims on the captured affiliate landing page.
3. Free consult and membership offers
IVIM explicitly offers a no-obligation free consultation valued at $75 for new patients and a limited offer free month membership with code GIFT75 in the captured content. Telos Rx messaging focuses on pricing if approved and pay $0 if not approved language, but the captured source did not show an equivalent free consult or promotional code.
Start IVIM Health free consult
4. Proprietary protocol and outcome claims
IVIM promotes a proprietary GLP-1 ID protocol and claims patients following that protocol lost an average of 46% more weight over 68 weeks compared to another published clinical GLP-1 trial, and also says GLP-1 ID can accelerate weight loss by up to 40% compared to standard GLP-1 protocols. The source emphasizes these are IVIM’s own protocol claims and not head to head randomized trials. Telos Rx does not publish a similar proprietary outcome claim in the captured material; it focuses on how semaglutide and tirzepatide act on GLP-1 or GLP-1 plus GIP and that a US-licensed provider decides which is right for you.
5. Compounded medication status and regulatory notices
Both providers’ captured content states that semaglutide and tirzepatide are compounded medications and prescription-only, and that compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. IVIM’s content repeats that compounded drugs have not undergone FDA review and explains medications are prepared by independent, licensed compounding pharmacies. Telos Rx likewise states treatments are subject to medical approval by a US-licensed provider and that compounded medications are not FDA-approved.
| Criteria | IVIM Health | Telos Rx |
|---|---|---|
| Advertised starting price | Semaglutide listed at $75/mo in landing details; FAQ shows $99 first month and $174/mo ongoing | Semaglutide as low as $99/mo; tirzepatide as low as $139/mo, price if approved |
| Third-party ratings | 4.9 stars on Google and Trustpilot reported | No verified third-party ratings captured |
| Free consult/membership | No-obligation free consult ($75 value) and GIFT75 free month membership | Captured content did not show a free consult or promo code |
| Protocol claims | Proprietary GLP-1 ID; claims up to 40% faster outcomes and a reported 46% greater weight loss in IVIM study comparison, not head to head | No proprietary efficacy claims captured; provider matches molecule to patient |
| Regulatory note | Compounded medications not FDA-approved; medications prepared by licensed compounding pharmacies | Compounded medications not FDA-approved; subject to clinician approval |
How to decide
Both platforms prescribe compounded semaglutide and tirzepatide only after clinician review and both note compounded medications are not FDA-approved. If your decision hinges on verified third-party satisfaction signals and an introductory free consult plus a promotional free month, IVIM Health’s captured materials support those features. If your decision is driven primarily by the lowest advertised starting price for semaglutide or tirzepatide as shown in the captured copy, Telos Rx advertises lower as-low-as starting points and emphasizes clinician approval and pricing dependence on plan.
Visit Telos Rx to confirm pricing and approval
Compare IVIM Health program details now
Choose IVIM Health if…
You value dual 4.9-star third-party ratings, want a documented no-obligation free consultation and an advertised free month with code GIFT75, and are interested in IVIM’s clinician-guided GLP-1 ID protocol and associated outcome claims as described in the source.
Choose Telos Rx if…
You prioritize the captured as-low-as starting prices for semaglutide ($99) or tirzepatide ($139) and want a provider that highlights clinician matching of molecule to patient and pricing that is subject to approval and plan.
Summary: For a quick comparison of IVIM Health vs Telos Rx, weigh IVIM’s free consult, membership code and dual 4.9-star ratings against Telos Rx’s lower advertised as-low-as starting prices and clinician approval language when deciding which compounded GLP-1 option to explore further.